Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Pellagra, caused by niacin deficiency and presenting with photosensitivity, should be considered in patients with relevant symptoms and risk factors.

Pharmacists play a key role in helping patients use over-the-counter products correctly, including those for hair regrowth and smoking cessation.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Different types of PCOS need specific diagnosis methods and treatments.

Animal research has greatly advanced dermatology.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.